Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection.
about
Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?Cytomegalovirus in pregnancy: to screen or not to screen.Emerging Role of Zika Virus in Adverse Fetal and Neonatal OutcomesCurrent and potential treatments for ubiquitous but neglected herpesvirus infectionsCongenital cytomegalovirus infection: Clinical presentation, epidemiology, diagnosis and preventionInfant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trialImaging the fetal central nervous system.Importance of diagnostic work-up of Guillain-Barré syndrome in pregnancy.Prenatal neurologic anomalies: sonographic diagnosis and treatment.Prevention of maternal cytomegalovirus infection: current status and future prospects.Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection.Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected womenModeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ cultureCytomegalovirus infection in pregnancy: review of the literaturePrevention of maternal and congenital cytomegalovirus infectionThe "silent" global burden of congenital cytomegalovirus.Twin pregnancy and congenital cytomegalovirus: case report and review.Effective management and intrauterine treatment of congenital cytomegalovirus infection: review article and case series.Diagnosis and prognosis of congenital CMV infection: a case report and review of the literature.Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity.Clinical course and management of acute and chronic viral hepatitis during pregnancy.Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.Optimum treatment of congenital cytomegalovirus infection.Congenital cytomegalovirus infection: contribution and best timing of prenatal MR imaging.Preventing Congenital Cytomegalovirus Infection.Fetal ascites owing to congenital cytomegalovirus: response to ganciclovir.TORCH screening in pregnancy. Where are we now? An audit of use in a tertiary level centre.The combination of specific IgM antibodies and IgG antibodies of low avidity does not always indicate primary infection with cytomegalovirus.Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort.Risk of cytomegalovirus-associated sequelae in relation to time of infection and findings on prenatal imaging.Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010.Fetal hyperechogenic bowel may indicate congenital cytomegalovirus disease responsive to immunoglobulin therapy.Maternal-fetal cytomegalovirus infection: from diagnosis to therapy.Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up.Guidelines on CMV congenital infection.Prevention of maternal-fetal transmission of cytomegalovirus.Can measurement of maternal anti-cytomegalovirus immunoglobulin-M antibody levels be used to screen for cytomegalovirus infection in embryos and fetuses?
P2860
Q26824199-B1DADABE-DC53-49C8-8171-C8D461D54496Q26851794-18B27E46-0214-4FE8-A1DE-2E9BF810EF82Q27010776-56F4D9D9-3811-43AC-A4D3-CA3104FA1E85Q27023452-1531D4BD-60B8-49B7-938F-C15CFDB43180Q27024030-6FDBE7EA-BACD-4909-BD4B-4206BC056016Q28730640-C13D62F3-8EDE-4431-8FEB-81AB54018737Q30439852-FB6C2FC1-8558-466C-99E3-0C1BB593C6E7Q33437291-54B97E71-CDD6-4233-8ECB-647F0D8D9466Q34126947-3D30DE2A-F8D3-483B-ADDB-8CA137BEBF63Q34272089-564A421F-787E-441D-84D1-2BF7B6C6D0FEQ34483696-B6FD9BDB-8596-4065-98FD-0ECD15D7F066Q35087763-205233FF-732E-41D8-932E-C16725C18DFAQ35599273-CFFE5666-4534-417B-AC5A-13E2A8731017Q35755969-29B53458-2A9E-413C-8B5C-B1D7B45716DAQ35945705-725EA954-440E-4C16-B9A5-7D01641794F9Q36558293-12DBACEC-CFAE-46DA-BF8F-FB3DF388055EQ38058345-D43D8FD6-1183-4F0A-BB70-54609139FD80Q38107519-6A9E34D3-25B1-431F-A165-52BA88C873B4Q38235995-C33E2B16-CD19-4867-ABB6-171082906AD7Q38246106-EC67C424-DAF9-4FCB-A8A5-ABF26653AFE4Q38257383-88B43B08-3125-42E8-A0C1-7B7BEC0E5C1CQ38260298-D4C10223-B10D-4C67-B8BC-99C3B41CEC5AQ38797872-08705E77-478D-474B-8E16-3F4AD9F63FBEQ39914550-C65F64EA-E8A3-4CCC-A666-BB1A8E811B54Q40086042-B65EFF9F-170A-4662-831A-7A632505301FQ41938833-18899376-147B-4CDD-A322-8C4A5D39E7CCQ42230668-43B4F0E3-69A6-408C-8F86-2ED95E31E01DQ42233996-75BF1796-7D36-45F4-84F6-A5E0BD1A0B12Q42275858-DD0D0317-99C3-4186-9C5B-DAAB1376A058Q42280136-29373513-BDAB-4F72-B151-D57BDFAB7F2FQ44168211-B316DCD4-FB09-458A-B17F-614FE018CBEBQ44735402-215FF2A9-AC4B-4C1F-95BE-32853C0D785EQ46104066-50E9ACDB-3FEA-4F6D-B6B1-6EBB1D79DCCCQ46511940-F2DDEC23-224C-4267-9C3A-8BEE04CA2E26Q48487817-BF4BD8C8-0973-4907-8FC3-8F4714736505Q51857092-C354070D-38A5-4AAA-84B3-225DBDEC99A2Q54306526-4815FD6F-B41E-4DC3-872F-C8DFAFB346DF
P2860
Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Maternal administration of val ...... ine cytomegalovirus infection.
@en
type
label
Maternal administration of val ...... ine cytomegalovirus infection.
@en
prefLabel
Maternal administration of val ...... ine cytomegalovirus infection.
@en
P2093
P2860
P1476
Maternal administration of val ...... ine cytomegalovirus infection.
@en
P2093
Jacquemard F
Jaqz-Aigrain E
Yamamoto M
P2860
P304
P356
10.1111/J.1471-0528.2007.01308.X
P577
2007-07-06T00:00:00Z